|
|
Analysis of prognosis of primary hepatic carcinoma patients with bone metastasis |
CHEN Chu1 and NI Huaikun2 |
1.Fuzhou Medical Team, Chinese People’s Armed Police Force, Fuzhou 350001,China; 2.Department of General Surgery, Fujian Provincial Hospital,Fuzhou 350001,China |
|
|
Abstract Objective To analyze factors that affect prognosis of patients of primary liver cancer (primary hepatic carcinoma PHC) with bone metastasis. Methods A retrospective analysis was made of the clinical effect of external irradiation among 112 cases of PHC with bone metastasis treated at Fujian Provincial Hospital. The pain caused by PHC with bone metastasis was graded. The 1, 2, and 3-year survival rate and the intensity of pain after radiation therapy were recorded. Such related factors as the gender of patients, liver lesions, bone metastasis, AFP levels, r-GT levels and control of lesions in the liver were analyzed using Kaplan-Meier method. The Logrank method was used for univariate analysis while the Cox regression model was used for multivariate analysis. Results Among the112 cases of PHC, 25.89% of the cases of bone metastasis were detected in lumbar, 19.64% in the sacro-iliac joint and 17.86% in the chest and ribs. The 3-year survival rate after the diagnosis of liver cancer was 15.18%, and thatof bone metastasis was 9.82%. The number of lesions, levels of bone metastasis in the liver, transfer of bone metastasis to other organs (tissues) were risk factors (P<0.05)that had some effect on the 3-year survival rate of patients of PHC with bone metastasis. The remaining factors were not significantly correlated with the survival rate. Conclusions The external radiation therapy can significantly alleviate the pain of patients of PHC with bone metastasis, but lower long-term survival rates, number of lesions in the liver, r-GT levels , bone metastases with other organs (tissues), foci in the liver and control of liver lesions affect the long-term survival rate of patients.
|
Received: 21 July 2016
|
|
|
|
|
[1] |
应希慧, 纪建松,涂建飞,等. 原发性肝癌合并骨转移45例临床分析[J]. 中华全科医学, 2014,12(8):1346-1347.
|
[2] |
刘 蒙, 董卫国. 原发性肝癌非手术治疗的研究进展[J]. 世界华人消化杂志,2009,17(12):1224-1228.
|
[3] |
金 生. 2010年美国肝病研究学会肝癌诊治指南要点介绍[J]. 实用肝脏病杂志,2011,14(3):227-240.
|
[4] |
肖亚景, 苏 敏, 杨 健, 等. 肝癌骨转移的特点及核素骨显像的价值[J]. 放射学实践,2004, 19(9):682-684.
|
[5] |
陈孝年.原发性肝癌外科治疗方法的选择[J].中国肝脏病杂志,2001,9(3):134-136.
|
[6] |
Ahn J,Flamm S L.Hepatocelluar carcinomal[J].Dis Mon,2004,50:556-573.
|
[7] |
中国抗癌协会专业委员会.原发性肝癌规范化诊治的专家共识[J].临床肝胆病杂志,2009,25(2):83-92.
|
[8] |
Hayashi S, Tanaka H, Hoshi H. Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma[J]. World J Hepatol, 2014,6(12):923-929.
|
[9] |
中华人民共和国卫生部. 原发性肝癌诊疗规范(2011年版) [J]. 临床肿瘤学杂志,2011, 16(10):929-946.
|
[10] |
Ruiz-Morales J M, Dorantes-Heredia R, Chable-Montero F, et al. Bone metastases as the initial presentation of hepatocellular carcinoma. Two case reports and a literature review[J]. Ann Hepatol, 2014,13(6):838-842.
|
[11] |
邱谢武, 于聪慧. 肝癌干细胞与肝癌复发转移的研究进展[J]. 世界华人消化杂志, 2011,19(17):1802-1807.
|
[12] |
Takahama J, Taoka T, Marugami N, et al. Hepatocellular carcinoma of the iliac bone with unknown primary[J]. Skeletal Radiol, 2010,39(7):721-724.
|
[13] |
Nemetz U, Tomazic P V, Walch C, et al. Pyramidal apex metastasis as primary manifestation of hepatocellular carcinoma[J]. Otol Neurotol, 2013,34(4):e30-e31.
|
[14] |
常中飞, 王茂强, 刘凤永, 等. 原发性肝细胞肝癌骨转移的临床及预后分析[J]. 中华临床医师杂志(电子版), 2013,7(15):6988-6992.
|
[15] |
Pan Z, Yang G, Yuan T, et al. Leptomeningeal metastasis from hepatocellular carcinoma with other unusual metastases: a case report[J]. BMC Cancer, 2014,14:399.
|
[16] |
Chua T C, Morris D L. Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma[J]. Surg Oncol, 2012,21(2):95-101.
|
[17] |
Xia F, Wu L, Lau W Y, et al. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis[J]. PLoS One, 2014,9(4):e95889.
|
[18] |
Kim S, Chun M, Wang H, et al. Bone metastasis from primary hepatocellular carcinoma: characteristics of soft tissue formation[J]. Cancer Res Treat, 2007,39(3):104-108.
|
|
|
|